These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 27352629)

  • 41. Undertreatment of osteoporosis and the role of gastrointestinal events among elderly osteoporotic women with Medicare Part D drug coverage.
    Siris ES; Yu J; Bognar K; DeKoven M; Shrestha A; Romley JA; Modi A
    Clin Interv Aging; 2015; 10():1813-24. PubMed ID: 26604724
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Socio-demographic factors influence chronic proton pump inhibitor use by a large population in the Netherlands.
    van Boxel OS; Hagenaars MP; Smout AJ; Siersema PD
    Aliment Pharmacol Ther; 2009 Mar; 29(5):571-9. PubMed ID: 19035978
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of the Prophylactic Use of Proton-Pump Inhibitors on the Pattern of Gastrointestinal Symptoms in Patients Late After Kidney Transplant.
    Królikowski J; Pawłowicz E; Budzisz E; Nowicki M
    Exp Clin Transplant; 2016 Oct; 14(5):503-510. PubMed ID: 27212101
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
    Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
    Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gastroesophageal reflux disease in primary care: using changes in proton pump inhibitor therapy as an indicator of partial response.
    Ruigómez A; Johansson S; Wernersson B; Fernández Cantero O; García Rodríguez LA
    Scand J Gastroenterol; 2012 Jul; 47(7):751-61. PubMed ID: 22519917
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Coexistence of osteoporosis and cardiovascular disease risk factors in apparently healthy, untreated postmenopausal women.
    Massé PG; Tranchant CC; Dosy J; Donovan SM
    Int J Vitam Nutr Res; 2005 Mar; 75(2):97-106. PubMed ID: 15929631
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Negative Association of Proton Pump Inhibitors With Subsequent Development of Breast Cancer: A Nationwide Population-Based Study.
    Chen CH; Lee CZ; Lin YC; Kao LT; Lin HC
    J Clin Pharmacol; 2019 Mar; 59(3):350-355. PubMed ID: 30329162
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Non-steroidal anti-inflammatory drugs use and risk of upper gastrointestinal adverse events in cirrhotic patients.
    Lee YC; Chang CH; Lin JW; Chen HC; Lin MS; Lai MS
    Liver Int; 2012 May; 32(5):859-66. PubMed ID: 22226322
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association of breast vascular calcifications with low bone mass in postmenopausal women.
    Nasser EJ; Iglésias ER; Ferreira JA; Fernandes CE; Pompei LM
    Climacteric; 2014 Aug; 17(4):486-91. PubMed ID: 24286614
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of the risk factors for osteoporosis among postmenopausal women.
    Demir B; Haberal A; Geyik P; Baskan B; Ozturkoglu E; Karacay O; Deveci S
    Maturitas; 2008; 60(3-4):253-6. PubMed ID: 18778903
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Defining Appropriate Use of Proton-Pump Inhibitors Among Medical Inpatients.
    Pappas M; Jolly S; Vijan S
    J Gen Intern Med; 2016 Apr; 31(4):364-71. PubMed ID: 26553337
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites.
    Bajaj JS; Zadvornova Y; Heuman DM; Hafeezullah M; Hoffmann RG; Sanyal AJ; Saeian K
    Am J Gastroenterol; 2009 May; 104(5):1130-4. PubMed ID: 19337238
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Proton Pump Inhibitors, Platelet Reactivity, and Cardiovascular Outcomes After Drug-Eluting Stents in Clopidogrel-Treated Patients: The ADAPT-DES Study.
    Weisz G; Smilowitz NR; Kirtane AJ; Rinaldi MJ; Parvataneni R; Xu K; Stuckey TD; Maehara A; Witzenbichler B; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Brodie BR; Mazzaferri EL; Mehran R; Stone GW
    Circ Cardiovasc Interv; 2015 Oct; 8(10):. PubMed ID: 26458411
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Proton pump inhibitors and osteoporosis.
    Andersen BN; Johansen PB; Abrahamsen B
    Curr Opin Rheumatol; 2016 Jul; 28(4):420-5. PubMed ID: 27224743
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparing resource utilization and gastrointestinal outcomes in patients treated with either standard-dose or high-dose proton pump inhibitors: a matched cohort study.
    Targownik LE; Metge C; Leung S
    Dig Dis Sci; 2008 Jun; 53(6):1519-26. PubMed ID: 17932757
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Non-guideline-recommended prescribing of proton pump inhibitors in the general population.
    Mares-García E; Palazón-Bru A; Martínez-Martín Á; Folgado-de la Rosa DM; Pereira-Expósito A; Gil-Guillén VF
    Curr Med Res Opin; 2017 Oct; 33(10):1725-1729. PubMed ID: 28318318
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk factors for dementia diagnosis in German primary care practices.
    Booker A; Jacob LE; Rapp M; Bohlken J; Kostev K
    Int Psychogeriatr; 2016 Jul; 28(7):1059-65. PubMed ID: 26744954
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prolonged Use of Proton Pump Inhibitors and Risk of Type 2 Diabetes: Results From a Large Population-Based Nested Case-Control Study.
    Ciardullo S; Rea F; Savaré L; Morabito G; Perseghin G; Corrao G
    J Clin Endocrinol Metab; 2022 Jun; 107(7):e2671-e2679. PubMed ID: 35428888
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An association between osteoporosis and premenstrual symptoms and postmenopausal symptoms.
    Lee SJ; Kanis JA
    Bone Miner; 1994 Feb; 24(2):127-34. PubMed ID: 8199532
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-Term Intake of Proton-Pump Inhibitors Could Be Associated with an Increased Incidence of Liver Cancer in Women.
    Loosen SH; Jördens MS; Leyh C; Luedde T; Roderburg C; Kostev K
    Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.